Francesca Avogadri-Connors's Colleagues at QED Therapeutics
Francesca Avogadri-Connors's Contact Details
HQ
650-231-4088
650-231-4088
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
QED Therapeutics
QED Therapeutics
Francesca Avogadri-Connors's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Francesca Avogadri-Connors
Francesca Avogadri-Connors currently works for QED Therapeutics.
Francesca Avogadri-Connors's role at QED Therapeutics is Director, Clinical Science.
Francesca Avogadri-Connors's email address is ***@qedtx.com. To view Francesca Avogadri-Connors's full email address, please signup to ConnectPlex.
Francesca Avogadri-Connors works in the Research industry.
Francesca Avogadri-Connors's colleagues at QED Therapeutics are Hiywot Takkele, Sherry Markle, Sudesh Kamath, Mag Sellakumaran, Kathleen Dm, Jack Winnike, Anne Lee and others.
Francesca Avogadri-Connors's phone number is 650-231-4088